Literature DB >> 24096576

Human ovarian tissue cortex surrounding benign and malignant lesions.

Mary Ellen Pavone1, Jennifer Hirshfeld-Cytron, Candace Tingen, Cristina Thomas, Jessina Thomas, M Patrick Lowe, Julian C Schink, Teresa K Woodruff.   

Abstract

OBJECTIVE: To quantify the number of follicles in patients with ovarian pathologies, benign and malignant, in pregnant and nonpregnant states and to determine how the presence of ovarian masses and BRCA status affects follicular counts.
MATERIALS AND METHODS: Slides from 134 reproductive-aged women undergoing oophorectomy were examined using light microscopy by 3 independent counters blinded to the diagnosis. In all, 20 patients had cancer, 69 had benign conditions, and 35 patients were BRCA+ or had a strong family history of breast and/or ovarian cancer. In all, 10 women were either pregnant or immediately postpartum.
RESULTS: Patients undergoing risk-reducing surgery had significantly decreased follicle count compared to physiologic control. Patients with cancer had significantly decreased counts compared to all other groups. There were no differences within the benign cohort.
CONCLUSIONS: When compared to benign masses, the cortex surrounding an ovarian malignancy has decreased follicle density. The stretch impact may minimize any impact on total follicle numbers. Furthermore, there may be a proliferation of ovarian stroma, with the same number of follicles spread over a larger surface area. This information is important when counseling women with ovarian masses regarding the use of ovarian tissue cryopreservation.

Entities:  

Keywords:  endometriosis; fertility preservation; follicle density; ovarian cancer; ovarian tissue cryopreservation; ovarian tissue transplantation

Mesh:

Year:  2013        PMID: 24096576      PMCID: PMC3984482          DOI: 10.1177/1933719113506498

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  58 in total

1.  Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients.

Authors:  Dror Meirow; Izhar Hardan; Jehoshua Dor; Eduard Fridman; Shai Elizur; Hila Ra'anani; Elena Slyusarevsky; Ninette Amariglio; Eyal Schiff; Gideon Rechavi; Arnon Nagler; Dina Ben Yehuda
Journal:  Hum Reprod       Date:  2008-03-15       Impact factor: 6.918

2.  Ovarian transplantation in a series of monozygotic twins discordant for ovarian failure.

Authors:  Sherman J Silber; Roger G Gosden
Journal:  N Engl J Med       Date:  2007-03-29       Impact factor: 91.245

Review 3.  Awakening the oocyte: controlling primordial follicle development.

Authors:  Eileen A McLaughlin; Skye C McIver
Journal:  Reproduction       Date:  2008-09-30       Impact factor: 3.906

4.  Dynamics of follicular growth in the human: a model from preliminary results.

Authors:  A Gougeon
Journal:  Hum Reprod       Date:  1986-02       Impact factor: 6.918

Review 5.  Fertility preservation: a comprehensive approach to the young woman with cancer.

Authors:  Jeffrey E Roberts; Kutluk Oktay
Journal:  J Natl Cancer Inst Monogr       Date:  2005

6.  Ovarian transplantation between monozygotic twins discordant for premature ovarian failure.

Authors:  Sherman J Silber; Kathleen M Lenahan; David J Levine; Jorge A Pineda; Kim S Gorman; Michael J Friez; Eric C Crawford; Roger G Gosden
Journal:  N Engl J Med       Date:  2005-06-07       Impact factor: 91.245

Review 7.  Fertility preservation in female patients.

Authors:  Murat Sonmezer; Kutluk Oktay
Journal:  Hum Reprod Update       Date:  2004 May-Jun       Impact factor: 15.610

8.  Morphometric studies of small follicles in ovaries of women at different ages.

Authors:  A Gougeon; G B Chainy
Journal:  J Reprod Fertil       Date:  1987-11

Review 9.  Preservation of fertility in patients with cancer.

Authors:  Jacqueline S Jeruss; Teresa K Woodruff
Journal:  N Engl J Med       Date:  2009-02-26       Impact factor: 91.245

10.  HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts.

Authors:  Song Yi Ko; Nicolas Barengo; Andras Ladanyi; Ju-Seog Lee; Frank Marini; Ernst Lengyel; Honami Naora
Journal:  J Clin Invest       Date:  2012-09-04       Impact factor: 14.808

View more
  10 in total

1.  Antimüllerian hormone levels are lower in BRCA2 mutation carriers.

Authors:  Lauren Johnson; Mary D Sammel; Susan Domchek; Allison Schanne; Maureen Prewitt; Clarisa Gracia
Journal:  Fertil Steril       Date:  2017-05       Impact factor: 7.329

2.  Ovarian Stimulation Is Safe and Effective for Patients with Gynecologic Cancer.

Authors:  Ruba A Akel; Xiaoyue M Guo; Molly B Moravek; Rafael Confino; Kristin N Smith; Angela K Lawson; Susan C Klock; Edward J Tanner Iii; Mary Ellen Pavone
Journal:  J Adolesc Young Adult Oncol       Date:  2020-01-10       Impact factor: 2.223

3.  Alginate encapsulation supports the growth and differentiation of human primordial follicles within ovarian cortical tissue.

Authors:  Monica M Laronda; Francesca E Duncan; Jessica E Hornick; Min Xu; Jennifer E Pahnke; Kelly A Whelan; Lonnie D Shea; Teresa K Woodruff
Journal:  J Assist Reprod Genet       Date:  2014-05-21       Impact factor: 3.412

4.  Ovarian Aging in Women With BRCA Germline Mutations.

Authors:  Wayne Lin; Shiny Titus; Fred Moy; Elizabeth S Ginsburg; Kutluk Oktay
Journal:  J Clin Endocrinol Metab       Date:  2017-10-01       Impact factor: 5.958

5.  Comparison between slow freezing and vitrification of ovarian tissue cryopreservation in assigned female at birth transgender people receiving testosterone therapy: data on histological and viability parameters.

Authors:  Aina Borrás; Dolors Manau; Francesc Fabregues; Sara Peralta; Josep Maria Calafell; Gemma Casals; Adela Saco; Inés Agustí; Francisco Carmona
Journal:  J Assist Reprod Genet       Date:  2022-01-31       Impact factor: 3.412

Review 6.  BRCA Mutations, DNA Repair Deficiency, and Ovarian Aging.

Authors:  Kutluk Oktay; Volkan Turan; Shiny Titus; Robert Stobezki; Lin Liu
Journal:  Biol Reprod       Date:  2015-07-29       Impact factor: 4.285

Review 7.  BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging.

Authors:  Volkan Turan; Kutluk Oktay
Journal:  Hum Reprod Update       Date:  2020-01-01       Impact factor: 15.610

8.  Navigating the body of literature assessing BRCA1/2 mutations and markers of ovarian function: a systematic review and meta-analysis.

Authors:  Christina N Cordeiro Mitchell; Bailey McGuinness; Eliana Fine; William G Kearns; Mindy S Christianson; James Segars; Lisa M Pastore
Journal:  J Assist Reprod Genet       Date:  2020-03-24       Impact factor: 3.412

9.  Immuno-Isolating Dual Poly(ethylene glycol) Capsule Prevents Cancer Cells from Spreading Following Mouse Ovarian Tissue Auto-Transplantation.

Authors:  James R Day; Anu David; Catherine Long; Grace G Bushnell; Teresa K Woodruff; Lonnie D Shea; Ariella Shikanov
Journal:  Regen Med Front       Date:  2019-09-16

10.  Do BRCA1 and BRCA2 gene mutation carriers have a reduced ovarian reserve? Protocol for a prospective observational study.

Authors:  Amy Louise Winship; Chris Willson; Karl R Hansen; Karla J Hutt; Martha Hickey
Journal:  BMJ Open       Date:  2019-11-25       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.